American Heart Association Honors MedRhythms and Vascudyne at Scientific Sessions 2026

The American Heart Association's Health Tech Competition awarded MedRhythms and Vascudyne top honors, highlighting technologies that could transform stroke rehabilitation and heart surgery.

Chicago Metrowire Staff
••Healthcare
American Heart Association Honors MedRhythms and Vascudyne at Scientific Sessions 2026

The American Heart Association recognized two health technology companies with top honors at its Health Tech Competition during Scientific Sessions 2026, underscoring the critical role of innovation in addressing cardiovascular and brain health challenges. MedRhythms, based in Portland, Maine, received the Best Business, Audience Choice and Best Overall awards for its digital health and neurotherapeutics solution that combines sensors, software and music to help people improve walking and mobility after stroke or other neurological injury or disease. Vascudyne, based in St. Paul, Minn., received the Best Science award for its bioengineered blood vessel technology, which is being developed to provide alternatives to harvesting a patient's leg vein for coronary bypass surgery and to create grafts for children with congenital heart defects that have the potential to grow with them.

The competition, hosted by the American Heart Association Center for Health Technology & Innovation, received a record number of submissions from health technology companies around the world. Following a rigorous multi-stage review by American Heart Association volunteer experts across healthcare, science and industry, five finalists were selected for their potential to improve how cardiovascular and brain health conditions are prevented, diagnosed and treated. The other finalists were HEARTio, MEGI and Seerlinq, each developing innovative solutions ranging from AI-powered ECG analysis to non-invasive cardiac pressure monitoring.

"The Health Tech Competition gives us a close look at technologies designed around real challenges facing patients and clinicians," said Lee Shapiro, JD, chairman of the board of the American Heart Association and managing partner of 7wire Ventures. "This year's winners demonstrated the attributes essential to advancing health technology: strong scientific evidence, meaningful business potential and innovative ways to address the challenges of those in need."

MedRhythms' at-home, prescription therapy uses precisely timed music cues to help retrain walking. Foot-worn sensors track the patient's walking, while software adjusts the music's rhythm to the person's movement. "Millions of people are living with walking difficulties after stroke, yet many have limited access to effective rehabilitation once they leave the clinic," said Brian Harris, founder and chief executive officer of MedRhythms. "This recognition helps raise awareness of the need stroke patients face and supports broader access for patients who could benefit from these therapies."

Vascudyne's ready-to-use blood vessel grafts are intended to reduce the need to harvest a vein from a patient's leg for bypass surgery and, for children with congenital heart defects, provide a conduit designed to grow with them. "Heart surgeons have always had to choose between living tissue harvested from the patient and off-the-shelf materials that can't heal or grow," said Zeeshan Syedain, PhD, chief executive officer and co-inventor of Vascudyne. "Our bioengineered vessel is both, ready on the shelf and designed to become the patient's own living tissue."

The recognition of these companies matters because it signals which innovations may soon reach patients. For stroke survivors, MedRhythms offers a potential solution to limited rehabilitation access, while Vascudyne's grafts could reduce surgical complications and improve outcomes for children with heart defects. The competition's emphasis on science and business viability helps bridge the gap between concept and clinical adoption. As the American Heart Association continues to champion health technology, the ahahealthtech.org/aha-health-tech-competition-2026 page provides more information. Additional details are available in the association's news release on Health tech competition finalists advance solutions for heart and brain health and the Global health tech competition aims to accelerate innovation improving cardiovascular and brain health.

For more information on the American Heart Association's efforts, visit heart.org and stroke.org.

Blockchain Registration

QR Code for Blockchain Registration